Recurring Clinical Review Capacity
A monthly reserved-capacity model for hospitals, RCM organizations, IDR operators, and AI appeal vendors. It converts heterogeneous work into “standard-equivalent units,” provides intake/suitability rules, consolidated invoicing, defined SLAs, and periodic pattern reporting based on client-supplied outcomes. The name should…
A bounded clinical support service.
A monthly reserved-capacity model for hospitals, RCM organizations, IDR operators, and AI appeal vendors. It converts heterogeneous work into “standard-equivalent units,” provides intake/suitability rules, consolidated invoicing, defined SLAs, and periodic pattern reporting based on client-supplied outcomes.
The name should be reviewed for procurement clarity. Because the public site disclaims U.S. licensure, Recurring Clinical Review Capacity may be the safer label unless “physician” is accompanied immediately by the named MBBS credential and limitation.
Scope boundary. The client retains filing, portal work, deadlines, signatures, coding, legal strategy, patient care, and any required U.S.-licensed or specialty opinion unless a separate approved scope expressly says otherwise.
The decision problem this service addresses.
Organizations with recurring but variable complex cases may need more than ad hoc purchasing and less than an FTE. Reserved capacity can improve predictability, while a suitability screen prevents routine or unsupported cases from consuming expert time.
What the review must resolve.
Case mix
Which deliverables and specialties recur, and what proportion is standard versus complex?
Volume
What minimum, average, peak, and seasonal volume should be reserved?
SLA
Which work needs priority review and which can use standard turnaround?
Intake
Who screens, de-identifies, assembles the record, confirms policy, and follows missing inputs?
Governance
How are credentials, authorship, branding, revisions, QA, and out-of-scope cases handled?
Outcomes
Which disposition and payment fields will the client return, and how will missing outcomes be shown?
The clinical work product.
- Reserved monthly capacity for agreed service types.
- Suitability triage of submitted cases, with accepted cases consuming units.
- Standard templates, SLA, and correction/change-of-scope rules.
- Monthly operational summary and quarterly pattern report if sufficient data exist.
- Outcome tracking only when the client returns disposition/payment data; no unsupported efficacy calculation.
What the client must supply.
Turnaround begins after the agreed record is complete and usable. New records, a different denial rationale, another review period, or a second independent issue can change scope.
- A representative pilot or sample set
- Expected volume, service mix, turnaround, and peak periods
- Record-assembly and policy-access workflow
- Security, BAA, credential, branding, and procurement requirements
- Named operational contacts, escalation rules, and outcome-return process
How buyers handle the work today.
- Full-time or fractional U.S.-licensed physician advisor.
- Managed-service or staff-augmentation contract.
- Enterprise denial/UM platform.
- Per-case freelancers or expert networks.
- Internal clinical pool supplemented by AI.
- Contingency recovery vendor.
The intended role in the workflow.
It provides predictable access to the same modular artifacts without an FTE commitment. Its limitation is single-founder/key-person capacity unless the approved contributor model, redundancy, and QA process are documented.
What the service is designed to prevent.
These are not proof that a denial is wrong. They are ways a potentially supportable case becomes unfocused, overstated, or routed to the wrong capability.
- Selling capacity before measuring actual case effort
- Using a monthly minimum to route unsuitable routine volume
- Promising one SLA for every service and complexity level
- Reporting outcomes without complete denominators
- Allowing branding to obscure authorship, credentials, or limits
Market comparison and current Clinovian scope.
The nearest public alternative is physician-advisor employment, but that includes licensed and organizational duties that Clinovian cannot claim. Enterprise retainers and staff augmentation are generally private. Therefore the proposed plans are cost-based packaging recommendations, not a reported market average.
Clinovian scope and pricing: Recurring arrangements begin from five deliverables per month. Pricing is based on work mix, volume, and turnaround and is confirmed after representative cases are reviewed.
Final scope, fixed fee, and turnaround are confirmed before records are transferred; the Engagements & Pricing page remains the public pricing framework.
When to choose it—and when not to.
Choose it after a pilot shows consistent case fit, usable deliverables, and enough monthly volume. Do not choose it before security/procurement review, when volume is highly uncertain, when every case requires a U.S.-licensed signature, or when the buyer needs 24/7/real-time coverage.
24. Engagement formats that should not be counted as additional services
The site also describes the following buying or workflow elements. They are useful, but counting them as separate clinical services would inflate the catalog.
Send the decision, not the whole account. Fit is confirmed before records.
Provide the denial or request type, payer or plan, review stage, record size, and client-controlled deadline. No PHI is required for the initial scope review.